Cite
APA Citation
Ylisaukko-oja, T., Af Björkesten, C. G., Erbel, A., Nuutinen, H., Jussila, A., Molander, P., Koskela, R., Blomster, T., Pajala, M., Ilus, T., Haiko, P., Kovac, B., Silvola, S., Smith, S., Jokelainen, J., & Sipponen, T. (n.d.). p629 Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment. Journal of Crohn's and colitis, 17, i758–i759. http://access.bl.uk/ark:/81055/vdc_100179844380.0x000018